Recombinant Human M2R Protein (HEK293)，Flag

The M2R, or muscarinic acetylcholine receptor type 2, is a critical component in the cholinergic signaling pathway, playing a pivotal role in various physiological functions, including cognition, cardiovascular regulation, and muscle contraction. Research into M2R recombinant proteins has gained momentum due to their significance in pharmacology and potential therapeutic applications, particularly in conditions like Alzheimer's disease, schizophrenia, and heart failure. These receptors are G-protein coupled receptors (GPCRs), making them a focus of drug development efforts aimed at targeting neuromuscular and neurodegenerative disorders. The ability to produce M2R as a recombinant protein allows for detailed structural and functional studies, contributing to the understanding of receptor mechanisms and interactions with ligands. Additionally, this approach facilitates the high-throughput screening of novel drug candidates, offering insights into the design of selective modulators that could improve clinical outcomes. Advancements in techniques such as cryo-electron microscopy and x-ray crystallography have further augmented the characterization of M2R, providing valuable data on its conformational states. Therefore, ongoing research on M2R recombinant proteins not only enhances our comprehension of cholinergic signaling but also holds promise for developing innovative therapeutic strategies that can effectively address central nervous system disorders and other diseases linked to M2R dysfunction.